Chief Executive Officer

DSM finishes sale of pharma assets to US firm

DSM finishes sale of pharma assets to US firm

By Hank Schultz

DSM has completed a major milestone in its restructuring into a smaller, more profitable and more focused company as it finalized the sale of its pharmaceutical manufacturing assets to US-based Thermo Fisher Scientific Inc.

Pharmavite appoints Jeff Boutelle as new CEO

Pharmavite appoints Jeff Boutelle as new CEO

By Adi Menayang

US manufacturer Pharmavite LLC, announced Jeff Boutelle as its new Chief Executive Officer and board member, effective August 7. Noriko Tojo, Pharmavite's current CEO will continue to serve as chair of Pharmavite's board and CEO of Otsuka Medical...

GNC to overhaul in-store experience in bid to halt sales slide

GNC to overhaul in-store experience in bid to halt sales slide

By Hank Schultz

Supplement retailing giant GNC will hit the reset button on its customer experience by closing all of its corporate-owned stores for one day next week to install new checkout terminals and institute a new pricing structure.

The Vitamin Shoppe joins UNPA as an Executive Member

The Vitamin Shoppe joins UNPA as an Executive Member

By Stephen Daniells

Citing a joint commitment to consumer trust, the Vitamin Shoppe has joined the United Natural Products Alliance (UNPA), an international association of forward-looking companies.

NDI draft guidance release is ‘curious timing’: BI chief

Dispatches from SupplySide West

NDI draft guidance release is ‘curious timing’: BI chief

By Stephen Daniells

The timing of the release of the new dietary ingredient (NDI) draft guidance is “curious” given pressing economic/resource issues and “far more serious issues that FDA should be looking at”, says the chief executive of BI Nutraceuticals.

Danisco buy-out fails to dent DuPont Q2 earnings

Danisco buy-out fails to dent DuPont Q2 earnings

By Shane Starling

Dupont, which earlier in the year warned that its May $6.49bn acquisition of Danisco would dent its yearly profits, has defied expectations in second quarter results published today.

April 2011 in pictures: Twinlab, gut health & Japan

April 2011 in pictures: Twinlab, gut health & Japan

By Stephen Daniells

As April draws to a close we look back at a month of news, which saw Twinlab appoint a new chief executive, FTC crack down on bogus acai-weight loss claims, and a breakthrough in gut health understanding.

Naturex set for “one or two” acquisitions in 2011: President

Naturex set for “one or two” acquisitions in 2011: President

By Shane Starling

Naturex will expand again in 2011 with several “€5-20m” targets, 1.5 years after completing the €110m integration of Spanish supplier Natraceutical that made the French botanical extracts supplier the biggest in the world.

Pontakios: Irradiation problems despite GMP crackdown

Dispatches from SupplySide West

Price drives ongoing illegal irradiation practices

By Shane Starling

Irradiation has risen in importance as it has become specifically outlawed in new Good Manufacturing Practice (GMP) regulations. But the practice continues due to its ability to cheaply remove contaminants from raw materials.

Robinson Pharma joins CRN

Robinson Pharma joins CRN

Californian-based Robinson Pharma Inc. has joined the Council for Responsible Nutrition (CRN) as a full voting member, a move it said reflects its desire to contribute to the overall well-being of the industry.

The devil in GMP details

DSHEA turns 15

The devil in GMP details

By Shane Starling

In the fifth and final installment of this DSHEA special, Frank Jaksch, the president and chief executive officer of Californian-based botanicals reference provider, Chromadex, outlines why he thinks current GMP inspection methodologies are unlikely to...

Too many trade groups spoil the lobbying broth?

Special edition: DSHEA turns 15

Too many trade groups spoil the lobbying broth?

By Shane Starling

In the third part of this DSHEA special, George Pontiakos, the president and chief executive officer of California-based, BI Nutraceuticals, tells Shane Starling why the dietary supplements industry suffers under the lack of a unified voice.

NPA: We need more cops, not laws

NPA: We need more cops, not laws

By Shane Starling

Responding to a call from the United States Anti-Doping Agency (USADA) for greater regulation of the dietary supplements industry, trade groups have defended the legal status quo – fingering a lack of policing for a rise in contamination problems from...

Pontiakos: FDA is doing a fine job

Pontiakos: FDA is doing a fine job

By Shane Starling

George Pontiakos, the president and chief executive officer of California-based, BI Nutraceuticals, tells Shane Starling why he thinks the Food and Drug Administration (FDA) should get more credit than it does.

Naturex president: acquisition policy remains unchanged

Exclusive interview

Naturex president: acquisition policy remains unchanged

By Shane Starling

Naturex president and chief executive officer, Jacques Dikansky, tells Shane Starling why in August the French botanicals giant bought Spanish supplier, Natraceutical Group, to double its size for the third time since 2002.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers